Celator Pharmaceuticals Inc — Form D

Celator Pharmaceuticals Inc of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-05-10. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Patrick D BradyDirectorVancouver, A1
Lawrence D MayerDirectorPrinceton, NJ
Nicole A VitulloDirectorSan Jose, CA
J. Kevin BuchiDirectorHayward, CA
Kenneth GalbraithDirectorVancouver, A1
Scott JacksonDirectorColumbia, MD
Scott JacksonExecutive OfficerColumbia, MD
Richard S KollenderDirectorPittsburgh, PA
Scott S MorensteinDirectorSan Diego, CA
David D WoodExecutive OfficerHouston, TX
Nicole S VitulloDirectorAnn Arbor, MI
Lawrence T MayerExecutive OfficerPrinceton, NJ
Joseph A MollicaDirectorPrinceton, NJ
Alex S ZissonDirectorPrinceton, NJ
Jackson T ScottDirectorPrinceton, NJ
Jackson T ScottExecutive OfficerPrinceton, NJ
Kenneth A GalbraithDirectorPrinceton, NJ
Lawrence D MayerExecutive OfficerPrinceton, NJ
Alex D ZissonDirectorStamford, CT
Brenda D Gavin, D.V.M.DirectorPhiladelphia, PA
Joseph A Molliica, Ph.D.DirectorPrinceton, NJ
Nicole D VitulloDirectorPrinceton, NJ
Brenda D GavinDirectorPhiladelphia, PA
Kenneth Kevin GalbraithDirectorVancouver, A1
Fred M PowellExecutive OfficerPlymouth Meeting, PA

Other filings by this issuer (4)

FiledFormOfferingSold
2013-05-13D/A$39.3M$39.3M
2012-08-30D$35.0M$4.1M
2011-12-28D$5.0M$2.6M
2010-09-07D$20.0M$15.0M

More